Abbott Laboratories (ABT) Stock Analysis
This is a peer-relative look at Abbott Laboratories (ABT): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Health Care Equipment & Services peers, so every number reads in context rather than in isolation.
Company Profile
| Profile Item | ABT |
|---|---|
| Name | Abbott Laboratories |
| Country/Region | United States |
| GICS Sector | Health Care |
| GICS Industry Group | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment |
| Market Capitalization | 173.61 billion USD |
| Currency | USD |
| Exchange | NYSE |
| Listing Date | March 17, 1980 |
| Security Type | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| Total Return (1Y) | -18.04% | 17.01% |
| Total Return (3Y, Annualized) | -2.45% | -0.94% |
| Total Return (5Y, Annualized) | -1.58% | -4.33% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| Volatility (1Y, Annualized) | 26.27% | 49.85% |
| Beta (5Y) | 0.60 | 0.87 |
| Max Drawdown (5Y) | -39.64% | -71.62% |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| Sharpe Ratio (1Y) | -0.84 | 0.28 |
| Sortino Ratio (1Y) | -1.18 | 0.45 |
Profitability
ROE (TTM)
No usable ROE is available for Abbott Laboratories (ABT) this period, so the shareholder-equity return read is skipped.
ABT
Health Care Equipment & Services industry group
--
Group distribution
- Max
- 53.65%
- Q3
- 13.93%
- Median
- 3.71%
- Q1
- -16.92%
- Min
- -59.21%
- ABT
- --
Largest peers
- ISRG
- 17.42%
- SYK
- 15.20%
- UNH
- 14.15%
- MDT
- 9.84%
- CVS
- 3.75%
- ABT
- --
- MCK
- --
Net Margin (TTM)
Abbott Laboratories (ABT) keeps 11.65% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.
ABT
Health Care Equipment & Services industry group
11.65%
Group distribution
- Max
- 30.40%
- ABT
- 11.65%
- Q3
- 8.56%
- Median
- 1.55%
- Q1
- -9.20%
- Min
- -34.34%
Largest peers
- ISRG
- 28.45%
- SYK
- 13.21%
- MDT
- 13.20%
- ABT
- 11.65%
- UNH
- 3.14%
- MCK
- 1.18%
- CVS
- 0.72%
Operating Margin (TTM)
Abbott Laboratories (ABT) turns 14.15% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.
ABT
Health Care Equipment & Services industry group
14.15%
Group distribution
- Max
- 37.54%
- ABT
- 14.15%
- Q3
- 12.86%
- Median
- 5.54%
- Q1
- -4.10%
- Min
- -25.61%
Largest peers
- ISRG
- 33.75%
- MDT
- 22.05%
- SYK
- 17.82%
- ABT
- 14.15%
- UNH
- 7.13%
- CVS
- 4.12%
- MCK
- 2.21%
Profitability Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| ROE (TTM) | -- | 3.71% |
| ROA (TTM) | -- | 3.01% |
| Net Margin (TTM) | 11.65% | 1.55% |
| Operating Margin (TTM) | 14.15% | 5.54% |
| Gross Margin (TTM) | 56.77% | 54.20% |
Growth
Revenue Growth
Abbott Laboratories (ABT) grew revenue 5.67%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.
EPS Growth
Abbott Laboratories (ABT) grew earnings per share -51.31%, in the lower peer quartile. Per-share profits are advancing more slowly than at most peers, so margins, costs, or share count deserve a closer look.
Growth Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 11.75% |
| Revenue Growth (3Y CAGR) | 0.51% | 11.37% |
| EPS Growth (YoY) | -51.31% | 4.84% |
| EPS Growth (3Y CAGR) | -1.65% | 13.94% |
Financial Strength
Current Ratio (MRQ)
No usable current ratio is available for Abbott Laboratories (ABT) this period, so the short-term liquidity read is skipped.
ABT
Health Care Equipment & Services industry group
--
Group distribution
- Max
- 7.79
- Q3
- 4.32
- Median
- 2.03
- Q1
- 1.34
- Min
- 0.04
- ABT
- --
Largest peers
- ISRG
- 6.43
- MDT
- 2.13
- SYK
- 2.11
- CVS
- 0.87
- MCK
- 0.85
- UNH
- 0.78
- ABT
- --
Debt / Equity (MRQ)
Abbott Laboratories (ABT) has debt-to-equity ratio of 0.65, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.
ABT
Health Care Equipment & Services industry group
0.65
Group distribution
- Max
- 2.02
- Q3
- 0.99
- ABT
- 0.65
- Median
- 0.58
- Q1
- 0.15
- Min
- 0.00
Largest peers
- CVS
- 1.01
- UNH
- 0.69
- SYK
- 0.66
- ABT
- 0.65
- MDT
- 0.58
- ISRG
- --
- MCK
- --
Financial Strength Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| Current Ratio (MRQ) | -- | 2.03 |
| Debt / Equity (MRQ) | 0.65 | 0.58 |
| Net Debt / EBITDA | 2.26 | 2.02 |
Dividends
Dividend Yield (TTM)
Abbott Laboratories (ABT) has dividend yield of 2.44%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.
ABT
Health Care Equipment & Services industry group
2.44%
Group distribution
- ABT
- 2.44%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- MDT
- 3.41%
- CVS
- 2.47%
- ABT
- 2.44%
- SYK
- 1.08%
- UNH
- 1.05%
- MCK
- 0.38%
- ISRG
- 0.00%
Dividend Payout Ratio (TTM)
Abbott Laboratories (ABT) has payout ratio of 78.96%, above the peer distribution for its industry. The dividend consumes more reported earnings than peers normally do, leaving unusually thin earnings cover.
ABT
Health Care Equipment & Services industry group
78.96%
Group distribution
- ABT
- 78.96%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- CVS
- 116.67%
- ABT
- 78.96%
- MDT
- 76.14%
- UNH
- 66.57%
- SYK
- 39.81%
- MCK
- 8.26%
- ISRG
- 0.00%
Dividend Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| Dividend Yield (TTM) | 2.44% | 0.00% |
| Dividend Payout Ratio (TTM) | 78.96% | 0.00% |
Valuation
P/E Ratio (TTM)
Abbott Laboratories (ABT) trades at P/E ratio of 32.89, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.
ABT
Health Care Equipment & Services industry group
32.89
Group distribution
- Max
- 73.47
- Q3
- 45.86
- ABT
- 32.89
- Median
- 30.56
- Q1
- 21.37
- Min
- 0.91
Largest peers
- CVS
- 47.26
- ISRG
- 40.47
- SYK
- 36.88
- ABT
- 32.89
- UNH
- 31.73
- MDT
- 22.32
- MCK
- 21.65
P/S Ratio (TTM)
Abbott Laboratories (ABT) trades at 3.73 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.
ABT
Health Care Equipment & Services industry group
3.73
Group distribution
- Max
- 8.58
- Q3
- 4.23
- ABT
- 3.73
- Median
- 2.05
- Q1
- 1.10
- Min
- 0.04
Largest peers
- ISRG
- 11.24
- SYK
- 4.77
- ABT
- 3.73
- MDT
- 2.90
- UNH
- 0.88
- CVS
- 0.35
- MCK
- 0.24
P/B Ratio (MRQ)
Abbott Laboratories (ABT) trades at 3.33 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.
ABT
Health Care Equipment & Services industry group
3.33
Group distribution
- Max
- 12.13
- Q3
- 5.82
- ABT
- 3.33
- Median
- 2.96
- Q1
- 1.56
- Min
- -2.02
Largest peers
- ISRG
- 7.10
- SYK
- 5.25
- UNH
- 3.78
- ABT
- 3.33
- MDT
- 2.13
- CVS
- 1.82
- MCK
- -45.79
Valuation Metrics
| Metric | Current stock: ABT | Industry group median |
|---|---|---|
| P/E Ratio (TTM) | 32.89 | 30.56 |
| P/S Ratio (TTM) | 3.73 | 2.05 |
| P/B Ratio (MRQ) | 3.33 | 2.96 |
| Free Cash Flow Yield (TTM) | -- | 3.73% |